Literature DB >> 27768109

Active actinium.

Gauthier J-P Deblonde1, Rebecca J Abergel1.   

Abstract

Year:  2016        PMID： 27768109     DOI： 10.1038/nchem.2653

Source DB:  PubMed          Journal:  Nat Chem        ISSN： 1755-4330            Impact factor:   24.427


× No keyword cloud information.
  5 in total

1.  Iranian researchers welcome nuclear deal.

Authors:  Davide Castelvecchi
Journal:  Nature       Date:  2015-07-23       Impact factor: 49.962

Review 2.  Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications.

Authors:  Matthias Miederer; David A Scheinberg; Michael R McDevitt
Journal:  Adv Drug Deliv Rev       Date:  2008-04-23       Impact factor: 15.470

3.  Spectroscopic and computational investigation of actinium coordination chemistry.

Authors:  Maryline G Ferrier; Enrique R Batista; John M Berg; Eva R Birnbaum; Justin N Cross; Jonathan W Engle; Henry S La Pierre; Stosh A Kozimor; Juan S Lezama Pacheco; Benjamin W Stein; S Chantal E Stieber; Justin J Wilson
Journal:  Nat Commun       Date:  2016-08-17       Impact factor: 14.919

4.  Gold coated lanthanide phosphate nanoparticles for targeted alpha generator radiotherapy.

Authors:  Mark F McLaughlin; Jonathan Woodward; Rose A Boll; Jonathan S Wall; Adam J Rondinone; Stephen J Kennel; Saed Mirzadeh; J David Robertson
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

5.  Preliminary Therapy Evaluation of (225)Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from (225)Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization.

Authors:  Darpan N Pandya; Roy Hantgan; Mikalai M Budzevich; Nancy D Kock; David L Morse; Izadora Batista; Akiva Mintz; King C Li; Thaddeus J Wadas
Journal:  Theranostics       Date:  2016-03-01       Impact factor: 11.556
  5 in total
  3 in total

1.  Melanocortin 1 Receptor-Targeted α-Particle Therapy for Metastatic Uveal Melanoma.

Authors:  Narges K Tafreshi; Christopher J Tichacek; Darpan N Pandya; Michael L Doligalski; Mikalai M Budzevich; HyunJoo Kil; Nikunj B Bhatt; Nancy D Kock; Jane L Messina; Epifanio E Ruiz; Nella C Delva; Adam Weaver; William R Gibbons; David C Boulware; Nikhil I Khushalani; Ghassan El-Haddad; Pierre L Triozzi; Eduardo G Moros; Mark L McLaughlin; Thaddeus J Wadas; David L Morse
Journal:  J Nucl Med       Date:  2019-02-07       Impact factor: 10.057

2.  Structure and properties of DOTA-chelated radiopharmaceuticals within the 225Ac decay pathway.

Authors:  Artem R Khabibullin; Aleksandra Karolak; Mikalai M Budzevich; Mark L McLaughlin; David L Morse; Lilia M Woods
Journal:  Medchemcomm       Date:  2018-06-06       Impact factor: 3.597

Review 3.  Progress in Targeted Alpha-Particle-Emitting Radiopharmaceuticals as Treatments for Prostate Cancer Patients with Bone Metastases.

Authors:  Chirayu M Patel; Thaddeus J Wadas; Yusuke Shiozawa
Journal:  Molecules       Date:  2021-04-09       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.